Effect of resveratrol on cultured skin fibroblasts from patients with oxidative phosphorylation defects

Phytotherapy Research

Volumn 28, Issue 2, 2014, Pages 312-316

  De Paepe, Boel ^a   Vandemeulebroecke, Katrien ^a   Smet, Joél ^a   Vanlander, Arnaud ^a   Seneca, Sara ^b   Lissens, Willy ^b   Van Hove, Johan Lk ^c   Deschepper, Ellen ^d   Briones, Paz ^e   Van Coster, Rudy ^a  

^a Laboratory for Child Neurology and Metabolism   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c Children's Hospital Colorado   (United States)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e CSIC   (Spain)

Author keywords

mitochondrial biogenesis; oxidative phosphorylation; resveratrol

Indexed keywords

MITOCHONDRIAL BIOGENESIS; OXIDATIVE PHOSPHORYLATION; RESVERATROL;

CELLS, CULTURED; CITRATE (SI)-SYNTHASE; CYTOCHROME-C OXIDASE DEFICIENCY; ELECTRON TRANSPORT COMPLEX II; ELECTRON TRANSPORT COMPLEX IV; FIBROBLASTS; HUMANS; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; STILBENES;

EID: 84892720251     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4988     Document Type: Article

References (15)

1. Bastin J, Aubey F, Rotig A, Munnich A, Djouadi F,. 2008. Activation of peroxisome proliferator-activated receptor pathway stimulates the mitochondrial respiratory chain and can correct deficiencies in patients' cells lacking its components. J Clin Endocrinol Metab 93: 1433-1441.
2. Bastin J, Lopes-Costa A, Djouadi F,. 2011. Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts. Hum Molec Genet 20: 2048-2057.
3. Csiszar A, Labinsky N, Pinto JT, et al,. 2009. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297: H13-H20.
4. Gerhart-Hines Z, Rodgers JT, Bare O, et al,. 2007. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J 26: 1913-1923.
5. Koene S, Smeitink J,. 2011. Metabolic manipulators: a well founded strategy to combat mitochondrial dysfunction. J Inherit Metab Dis 34: 315-325.
6. Lagouge M, Argmann C, Gerhart-Hines Z, et al,. 2006. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127: 1109-1122.
7. Navarro-Sastre A, Tort F, Stehling O, et al,. 2011. A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. Am J Hum Genet 89: 656-667.
8. Park SJ, Ahmad F, Philp A, et al,. 2012. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 148: 421-433.
9. Srivastava S, Diaz F, Iommarini L, Aure K, Lombes A, Moraes CT,. 2009. PGC-1a/b induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum Molec Genet 18: 1805-1812.
10. Taivassalo T, Haller RG,. 2004. Implications of exercise training in mtDNA defects-use it or lose it? Biochim Biophys Acta 1659: 221-231.
11. Tennen RI, Michishita-Kioi E, Chua KF,. 2012. Finding a target for resveratrol. Cell 148: 387-389.
12. Van Coster R, Seneca S, Smet J, et al., 2003. Homozygous Gly555Glu mutation in the nuclear-encoded 70 kDa flavoprotein gene causes instability of the respiratory chain complex II. Am J Med Genet 120: 13-18.
13. Van Coster R, Smet J, George E, et al,. 2001. Blue native polyacrylamide gel electrophoresis: a powerful tool in diagnosis of oxidative phosphorylation defects. Pediatr Res 50: 658-665.
14. Wenz T, Diaz F, Spiegelman BM, Moraes CT,. 2008. Activation of the PPAR/PGC-1 alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy genotype. Cell Metab 8: 249-256.
15. Zeviani M, Di Donato S,. 2004. Mitochondrial disorders. Brain 127: 2153-2172.